Ubs Group Ag Biophytis Sa Transaction History

Ubs Group Ag

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.35 - $0.67 $3,209 - $6,143	-9,169 Reduced 60.01%	6,110 $2,000
Q3 2022 Nov 10, 2022	BUY	$0.64 - $1.27 $9,178 - $18,214	14,342 Added 1530.63%	15,279 $9,000
Q2 2022 Aug 10, 2022	BUY	$0.98 - $2.57 $452 - $1,187	462 Added 97.26%	937 $1,000
Q1 2022 May 16, 2022	SELL	$2.5 - $5.37 $1,725 - $3,705	-690 Reduced 59.23%	475 $1,000
Q4 2021 Feb 14, 2022	SELL	$4.86 - $8.37 $641 - $1,104	-132 Reduced 10.18%	1,165 $6,000
Q3 2021 Nov 15, 2021	BUY	$7.93 - $10.6 $8,382 - $11,204	1,057 Added 440.42%	1,297 $11,000
Q2 2021 Aug 13, 2021	SELL	$10.2 - $15.21 $9,139 - $13,628	-896 Reduced 78.87%	240 $3,000
Q1 2021 May 12, 2021	BUY	$12.8 - $17.02 $14,540 - $19,334	1,136 New	1,136 $15,000

Ticker BPTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,382,400
Market Cap $115M
Description
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.